KALA PHARMACEUTICALS INC's ticker is KALA and the CUSIP is 483119103. A total of 71 filers reported holding KALA PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.66 and the average weighting 0.0%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $3,000 | -40.0% | 14,834 | -2.8% | 0.00% | – |
| Q2 2022 | $5,000 | -84.8% | 15,260 | -35.4% | 0.00% | – |
| Q1 2022 | $33,000 | -8.3% | 23,625 | -20.8% | 0.00% | – |
| Q4 2021 | $36,000 | +16.1% | 29,842 | +150.0% | 0.00% | – |
| Q3 2021 | $31,000 | -34.0% | 11,935 | +33.8% | 0.00% | – |
| Q2 2021 | $47,000 | -66.4% | 8,922 | -57.1% | 0.00% | – |
| Q1 2021 | $140,000 | +77.2% | 20,818 | +78.6% | 0.00% | – |
| Q4 2020 | $79,000 | -14.1% | 11,655 | -5.1% | 0.00% | – |
| Q3 2020 | $92,000 | -98.0% | 12,275 | -97.2% | 0.00% | -100.0% |
| Q2 2020 | $4,590,000 | +6457.1% | 436,702 | +5387.6% | 0.00% | – |
| Q1 2020 | $70,000 | +159.3% | 7,958 | +7.8% | 0.00% | – |
| Q4 2019 | $27,000 | +200.0% | 7,379 | +217.5% | 0.00% | – |
| Q3 2019 | $9,000 | -78.6% | 2,324 | -65.0% | 0.00% | – |
| Q2 2019 | $42,000 | +5.0% | 6,640 | +36.3% | 0.00% | – |
| Q1 2019 | $40,000 | +135.3% | 4,870 | +41.5% | 0.00% | – |
| Q4 2018 | $17,000 | -32.0% | 3,442 | +35.2% | 0.00% | – |
| Q3 2018 | $25,000 | +66.7% | 2,545 | +126.6% | 0.00% | – |
| Q2 2018 | $15,000 | -70.6% | 1,123 | -64.8% | 0.00% | – |
| Q1 2018 | $51,000 | +70.0% | 3,191 | +94.0% | 0.00% | – |
| Q4 2017 | $30,000 | -97.8% | 1,645 | -97.2% | 0.00% | -100.0% |
| Q3 2017 | $1,348,000 | – | 59,013 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CAXTON CORP | 1,430,021 | $9,638,000 | 6.26% |
| RA Capital Management | 10,874,613 | $73,295,000 | 1.10% |
| Mesirow Financial Investment Management, Inc. | 41,961 | $283,000 | 0.77% |
| Samsara BioCapital, LLC | 601,162 | $4,052,000 | 0.75% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 102,198 | $689,000 | 0.38% |
| Eventide Asset Management | 3,450,000 | $23,253,000 | 0.34% |
| Orbimed Advisors | 5,465,030 | $36,834,000 | 0.34% |
| Parkman Healthcare Partners LLC | 148,433 | $1,000,000 | 0.23% |
| Vivo Capital, LLC | 786,883 | $5,304,000 | 0.19% |
| Knights of Columbus Asset Advisors LLC | 199,954 | $1,348,000 | 0.13% |